Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes

被引：21
|
作者：
Imprialos, Konstantinos P. [1 ]
Stavropoulos, Konstantinos [1 ]
Doumas, Michael [2 ]
机构：
[1] Aristotle Univ Thessaloniki, Thessaloniki, Greece
[2] George Washington Univ, Washington, DC USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 377卷 / 25期
关键词：
D O I：
10.1056/NEJMc1714163
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2502 / 2502
页数：1
相关论文
共 50 条
  • [31] Comparison of once-weekly with twice-daily exenatide in the treatment of type 2 diabetes (DURATION-1 trial)
    Raskin, Philip
    Mohan, Alok
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (13) : 2269 - 2271
  • [32] Predictors of Glycemic and Weight Response to Exenatide Once-Weekly in Patients with Type 2 Diabetes in a Real-World Setting
    Gorgojo-Martinez, Juan J.
    Brito-Sanfiel, Miguel A.
    Gargallo-Fernandez, Manuel A.
    Lisbona-Catalan, Arturo
    DIABETES, 2017, 66 : A297 - A297
  • [33] LONG-TERM CLINICAL OUTCOMES OF EXENATIDE ONCE-WEEKLY VERSUS INSULIN GLARGINE FOR THE TREATMENT OF TYPE 2 DIABETES PROJECTED USING THE CORE DIABETES MODEL
    Timlin, L.
    Beaudet, A.
    Wilson, B.
    Bruhn, D.
    Boye, K. S.
    Palmer, J. L.
    Lloyd, A.
    VALUE IN HEALTH, 2010, 13 (07) : A284 - A285
  • [34] Efficacy and Safety of Once-Weekly Semaglutide vs. Exenatide ER in Subjects with Type 2 Diabetes (SUSTAIN 3)
    Ahmann, Andrew J.
    Capehorn, Matthew
    Charpentier, Guillaume
    Dotta, Francesco
    Henkel, Elena
    Lingvay, Ildiko
    Holst, Anders Gaarsdal
    Chang, Denise
    Aroda, Vanita R.
    DIABETES, 2016, 65 : A49 - A49
  • [35] Effect of once-weekly exenatide on hospitalization for acute coronary syndrome or coronary revascularization in patients with type 2 diabetes mellitus
    Barbery, Carlos E.
    Giczewska, Anna
    White, Jennifer
    Lokhnygina, Yuliya
    Mentz, Robert John
    Holman, Rury R.
    Pagidipati, Neha
    Hernandez, Adrian F.
    Jones, W. Schuyler
    AMERICAN HEART JOURNAL, 2021, 239 : 59 - 63
  • [36] Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial
    Becker, F.
    Dakin, H.
    Reed, S. D.
    Li, Y.
    Leal, J.
    Gustavson, S. M.
    Kartman, B.
    Wittbrodt, E.
    Gray, A. M.
    Hernandez, A. F.
    Holman, R. R.
    DIABETOLOGIA, 2018, 61 : S366 - S366
  • [37] Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease: Prespecified Analysis From EXSCEL
    Mentz, Robert J.
    Thompson, Vivian P.
    Aguilar, David
    Choi, Jasmine
    Gustavson, Stephanie M.
    Iqbal, Nayyar
    Kong, Alice P.
    Ohman, Peter
    Sattar, Naveed
    Scott, Russell S.
    Wong, Yee Weng
    Holman, Rury R.
    Hernandez, Adrian F.
    CIRCULATION, 2018, 138 (22) : 2576 - 2578
  • [38] User Evaluation of the Exenatide Once-Weekly Suspension Autoinjector
    Larue, Susan
    Springer, Jane
    Meehan, James
    Wysham, Carol H.
    DIABETES, 2017, 66 : A296 - A297
  • [39] Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes
    Tan, Xueying
    Cao, Xiaojing
    Zhou, Minzhi
    Zou, Ping
    Hu, Jingbo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (09) : 1083 - 1089
  • [40] Diabetes once-weekly drug
    Gunjan Sinha
    Nature Biotechnology, 2012, 30 (3) : 201 - 201
12345